Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net loss $ (1,784,539) $ (1,375,795)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense included in - General and administrative costs 772,390 5,681
Stock-based compensation expense included in - Research and development costs 32,020
(Increase) decrease in -    
Advances on research and development contract services 183,490
Prepaid expenses and other current assets (8,248) (10,806)
Increase (decrease) in -    
Accounts payable and accrued expenses 84,559 3,589
Research and development contract liabilities 1,450 33,973
Net cash used in operating activities (934,388) (1,127,848)
Cash flows from financing activities:    
Exercise of common stock options 3,000 18,000
Proceeds from sale of common stock 2,500,000
Net cash provided by financing activities 3,000 2,518,000
Cash:    
Net increase (decrease) (931,388) 1,390,152
Balance at beginning of period 1,305,748 199,929
Balance at end of period 374,360 1,590,081
Supplemental disclosures of cash flow information:    
Interest
Income taxes